Why The $40.5 Billion Acquisition Of Allergan's Generic Business For Teva Is 'Right Deal At The Right Time'

By: via Benzinga
Teva Pharmaceutical Industries Ltd (ADR)(NYSE: TEVA) and Allergan PLC (NYSE: AGN) on Monday announced that the former would be ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.